Literature DB >> 25638642

C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.

Jonathan D Rohrer1, Adrian M Isaacs2, Sarah Mizielinska2, Simon Mead3, Tammaryn Lashley4, Selina Wray5, Katie Sidle5, Pietro Fratta2, Richard W Orrell5, John Hardy5, Janice Holton4, Tamas Revesz4, Martin N Rossor6, Jason D Warren6.   

Abstract

C9orf72 hexanucleotide repeat expansions are the most common cause of familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) worldwide. The clinical presentation is often indistinguishable from classic FTD or ALS, although neuropsychiatric symptoms are more prevalent and, for ALS, behavioural and cognitive symptoms occur more frequently. Pathogenic repeat length is in the hundreds or thousands, but the minimum length that increases risk of disease, and how or whether the repeat size affects phenotype, are unclear. Like in many patients with FTD and ALS, neuronal inclusions that contain TARDBP are seen, but are not universal, and the characteristic pathological finding is of dipeptide repeat (DPR) proteins, formed by unconventional repeat-associated non-ATG translation. Possible mechanisms of neurodegeneration include loss of C9orf72 protein and function, RNA toxicity, and toxicity from the DPR proteins, but which of these is the major pathogenic mechanism is not yet certain.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25638642     DOI: 10.1016/S1474-4422(14)70233-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  84 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

3.  Changing epidemiology of motor neurone disease in Scotland.

Authors:  Danielle J Leighton; Judith Newton; Laura J Stephenson; Shuna Colville; Richard Davenport; George Gorrie; Ian Morrison; Robert Swingler; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2019-02-25       Impact factor: 4.849

Review 4.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 5.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 6.  Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.

Authors:  Hannah E Silverman; Jill S Goldman; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

7.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

8.  Phase Separation of Toxic Dipeptide Repeat Proteins Related to C9orf72 ALS/FTD.

Authors:  Hamidreza Jafarinia; Erik van der Giessen; Patrick R Onck
Journal:  Biophys J       Date:  2020-07-16       Impact factor: 4.033

Review 9.  Amyotrophic Lateral Sclerosis: Current Status in Diagnostic Biomarkers.

Authors:  Katerina Kadena; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.

Authors:  Adriano Chiò; Gabriele Mora; Mario Sabatelli; Claudia Caponnetto; Christian Lunetta; Bryan J Traynor; Janel O Johnson; Mike A Nalls; Andrea Calvo; Cristina Moglia; Giuseppe Borghero; Francesca Trojsi; Vincenzo La Bella; Paolo Volanti; Isabella Simone; Fabrizio Salvi; Francesco O Logullo; Nilo Riva; Paola Carrera; Fabio Giannini; Jessica Mandrioli; Raffaella Tanel; Margherita Capasso; Lucio Tremolizzo; Stefania Battistini; Maria Rita Murru; Paola Origone; Marcella Zollino; Silvana Penco; Letizia Mazzini; Sandra D'Alfonso; Gabriella Restagno; Maura Brunetti; Marco Barberis; Francesca L Conforti
Journal:  Neurobiol Aging       Date:  2015-12-08       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.